Nutritional supplements in amyotrophic lateral sclerosis.
D000284:Administration, Oral; D000328:Adult; D000690:Amyotrophic Lateral Sclerosis / Q000150:complications / Q000188:drug therapy*; D002100:Cachexia / Q000188:drug therapy / Q000209:etiology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005218:Fat Necrosis / Q000209:etiology; D005233:Fatty Alcohols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011897:Random Allocation; D014810:Vitamin E / Q000008:administration & dosage / Q000627:therapeutic use
D005233:Fatty Alcohols; D014810:Vitamin E; C044309:1-octacosanol